Aarvik Therapeutics is a biotechnology company dedicated to engineering precision therapies for oncology targets.
Aarvik Therapeutics has raised $2.0M in total funding. The most recent round was Seed. The last funding was announced in September 2025.
Aarvik Therapeutics's investors include Laurus Labs.
Aarvik Therapeutics is headquartered in Fremont, United States.
Aarvik Therapeutics is a biotechnology company dedicated to engineering precision therapies for oncology targets.
Aarvik Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aarvik Therapeutics — Funding & Investors." VCBacked, September 29, 2025, https://www.vcbacked.co/company/aarvik-therapeutics. Accessed November 14, 2026.
VCBacked. (2025). Aarvik Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/aarvik-therapeutics
{{cite web |title=Aarvik Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/aarvik-therapeutics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Aarvik Therapeutics? Request a listing update